Get emailed when ABUS changes direction
Factor Model (net -0.9)
Factor Model
net -0.9
Est. Revisions
+0.1
Insider Activity
+0.0
Momentum
+0.0
Analyst Rev.
-1.0
Narrative Gap
+0.0
Analysis pending — waiting for first signal cycle.
Evidence
Fundamentals & Data ▾
Arbutus Biopharma Corporation
Healthcare · Biotechnology
Mkt Cap
$829M
Beta
0.74
52w Range
$2.94 - $5.10
Short Interest
16.2M 12.24%
Days to Cover
5.6 +10%
Technicals
downtrend
from 52w Hi
-9.3%
1w return
-7.0%
Insiders
selling
0B / 4S
EPS Estimate
$-0.06
+1.8% 30d
0up / 1dn
Est. Dispersion
0%
1 analysts
Analyst Target
$5
$5 - $6
Options P/C
0.55
Insider Cluster
strong sell
0B / 4S
Fund Convergence
moderate
D.E. Shaw, Citadel
Financials
Revenue
$1M -33% YoY
FCF
$-5M
Op Margin
-727%
Momentum:
accelerating
Top Holders
D.E. Shaw
$2M
Citadel
Recent Filings & Data
insider trade
12
net selling
· $206,189 sold
8 insiders · 12 transactions (30d)
Recent transactions
ANDROSKI LINDSAY J.D. · award
NGUYEN TUAN · award
NAFTZGER J CHRISTOPHER · award
HASTINGS DAVID C · award
SIMS KAREN · award
NAFTZGER J CHRISTOPHER · sell · $37,206
HASTINGS DAVID C · sell · $72,827
SIMS KAREN · sell · $63,519
MANCHESTER KEITH S · sell · $32,637
MANCHESTER KEITH S · exercise · $30,752
Androski (Lindsay J.D.) · other
Nguyen (Tuan) · other
2 signals · latest 4d ago
Get alerted when ABUS changes direction
We'll email you when our AI detects a shift — reversals, insider clusters, filing red flags.